Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma
- Pablo E. Serrano
- , Joseph M. Herman
- , Kent A. Griffith
- , Mark M. Zalupski
- , Edward J. Kim
- , Tanios S. Bekaii-Saab
- , Edgar Ben-Josef
- , Laura A. Dawson
- , Jolie Ringash
- , Alice C. Wei
Research output: Contribution to journal › Article › peer-review
36
Link opens in a new tab
Scopus
citations